Cargando…

Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis

[Image: see text] Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacological potency and selectivity. Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood. Here, we report a novel class of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Shyam, Miller, Rand M., Tian, Boxue, Mullins, R. Dyche, Jacobson, Matthew P., Taunton, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160273/
https://www.ncbi.nlm.nih.gov/pubmed/25153195
http://dx.doi.org/10.1021/ja505194w
_version_ 1782334374583205888
author Krishnan, Shyam
Miller, Rand M.
Tian, Boxue
Mullins, R. Dyche
Jacobson, Matthew P.
Taunton, Jack
author_facet Krishnan, Shyam
Miller, Rand M.
Tian, Boxue
Mullins, R. Dyche
Jacobson, Matthew P.
Taunton, Jack
author_sort Krishnan, Shyam
collection PubMed
description [Image: see text] Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacological potency and selectivity. Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood. Here, we report a novel class of acrylonitrile-based Michael acceptors, activated by aryl or heteroaryl electron-withdrawing groups. We demonstrate that thiol adducts of these acrylonitriles undergo β-elimination at rates that span more than 3 orders of magnitude. These rates correlate inversely with the computed proton affinity of the corresponding carbanions, enabling the intrinsic reversibility of the thiol-Michael reaction to be tuned in a predictable manner. We apply these principles to the design of new reversible covalent kinase inhibitors with improved properties. A cocrystal structure of one such inhibitor reveals specific noncovalent interactions between the 1,2,4-triazole activating group and the kinase. Our experimental and computational study enables the design of new Michael acceptors, expanding the palette of reversible, cysteine-targeted electrophiles.
format Online
Article
Text
id pubmed-4160273
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-41602732014-09-16 Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis Krishnan, Shyam Miller, Rand M. Tian, Boxue Mullins, R. Dyche Jacobson, Matthew P. Taunton, Jack J Am Chem Soc [Image: see text] Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacological potency and selectivity. Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood. Here, we report a novel class of acrylonitrile-based Michael acceptors, activated by aryl or heteroaryl electron-withdrawing groups. We demonstrate that thiol adducts of these acrylonitriles undergo β-elimination at rates that span more than 3 orders of magnitude. These rates correlate inversely with the computed proton affinity of the corresponding carbanions, enabling the intrinsic reversibility of the thiol-Michael reaction to be tuned in a predictable manner. We apply these principles to the design of new reversible covalent kinase inhibitors with improved properties. A cocrystal structure of one such inhibitor reveals specific noncovalent interactions between the 1,2,4-triazole activating group and the kinase. Our experimental and computational study enables the design of new Michael acceptors, expanding the palette of reversible, cysteine-targeted electrophiles. American Chemical Society 2014-08-25 2014-09-10 /pmc/articles/PMC4160273/ /pubmed/25153195 http://dx.doi.org/10.1021/ja505194w Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Krishnan, Shyam
Miller, Rand M.
Tian, Boxue
Mullins, R. Dyche
Jacobson, Matthew P.
Taunton, Jack
Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title_full Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title_fullStr Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title_full_unstemmed Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title_short Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
title_sort design of reversible, cysteine-targeted michael acceptors guided by kinetic and computational analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160273/
https://www.ncbi.nlm.nih.gov/pubmed/25153195
http://dx.doi.org/10.1021/ja505194w
work_keys_str_mv AT krishnanshyam designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis
AT millerrandm designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis
AT tianboxue designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis
AT mullinsrdyche designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis
AT jacobsonmatthewp designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis
AT tauntonjack designofreversiblecysteinetargetedmichaelacceptorsguidedbykineticandcomputationalanalysis